Source: OptiScan Imaging
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • OptiScan Imaging (OIL) has changed its distribution arrangements
  • The company has entered into an agreement with Advanced Microscopy Consultancy Services (AMCS)
  • AMCS will provide technical, marketing and sales services to OptiScan in the U.S. and Canada
  • This means OptiScan has ended its distribution agreement with Scinitca Instrumentation although it continues to explore potential opportunities to work with Scinitca
  • The altering of the agreements follows the company’s recent engagement with a consultant, Dr Joesph Jiafu
  • On the market close, Optiscan is down 6.67 per cent and last traded for 5.6 cents

Microscopic imaging company OptiScan Imaging (OIL) has changed its North American distribution arrangements.

The company has entered into an agreement with Advanced Microscopy Consultancy Services (AMCS) to provide technical, marketing and sales services to OptiScan in the U.S. and Canada.

AMCS provides significant pre-clinical microscopy and imaging services and has multiple contacts in the research community.

This means OptiScan has ended its distribution agreement with Scinitca Instrumentation although it continues to explore potential opportunities to work with Scinitca.

The altering of the agreements follows the company’s recent engagement with a consultant, Dr Joesph Jiafu. Joesph was hired to assist OptiScan to establish distribution arrangements in Japan, Korea, Singapore and other Asia Pacific countries (excluding China).

“We are excited to build upon our recent sales in the China market by adding highly qualified and experienced people to develop sales and distribution
opportunities in North America and Asia,” Executive Chair and CEO Darren Lurie said.

‘In addition, we have been able to enhance the technical, microscopy and pre-clinical application knowledge within the Company which will benefit us in all market,” he added.

On the market close, Optiscan is down 6.67 per cent and last traded for 5.6 cents

OIL by the numbers
More From The Market Online

Pacific Edge revenues up, cash costs down on reorganisation

Pacific Edge Ltd has balanced a drop in cash costs with falls in total cash at…

Telix Pharma gears up to launch US IPO

Telix Pharmaceuticals has announced it's working with Morgan Stanley to list depository shares on the NASDAQ.

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…